The Risk of Hemorrhage and Nursing Care in Patients with Crimean-Congo Hemorrhagic Fever/ Kırım-Kongo Kanamalı Ateşi Tanılı Hastalarda Kanama Riski ve Hemşirelik Bakımı
Abstract
Thrombocytopenia is seen at a rate of 95-100% in patients diagnosed with Crimean-Congo Hemorrhagic Fever (CCHF). Activation of the coagulation cascade with the effect of endothelial damage leads to thrombocytopenia, hemorrhage, disseminated intravascular coagulation, and multi-organ failure. The presence of poor prognosis factors causes the thrombocytopenia to rapidly deepen, and insufficient transfusion causes increased mortality rates. In patients with CCHF, independent nursing interventions include identification of hemorrhage/hemorrhage risk, determining the factors causing hemorrhage, and solving the hemorrhage risk problem. Hence, the nurses who work in the unit where CCHF patients are treated should identify the hemorrhage risk in detail, specify individualized nursing interventions, follow evidence-based practice and be in collaboration with other health staff. This review presents information about nursing care aiming at hemorrhage/ hemorrhage risk developing from thrombocytopenia in patients with CCHF.
Keywords: Crimean-Congo Hemorrhagic Fever; Hemorrhage; Nursing Care; Thrombocytopenia.
Keywords
References
- 1. Crimean-Congo haemorrhagic fever [WHO website]. January 2013. Available at: https://www.who.int/news-room/factsheets/detail/crimean-congo-haemorrhagic-fever. Accessed February 27, 2021.
- 2. Introduction to Crimean-Congo Haemorrhagic Fever [WHO website]. December 2019. Available at: https://www.who.int/publications/i/item/introduction-to-crimean-congo-haemorrhaigc-fever. Accessed February 27, 2021.
- 3. Mertens M, Schmidt K, Ozkul A, Groschup, MH. The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral research. 2013; 98(2): 248-260. https://doi.org/10.1016/j.antiviral.2013.02.007
- 4. Ince Y, Yasa C, Metin M, Sonmez M, Meram E, Benkli B, et al. Crimean-Congo hemorrhagic fever infections reported by ProMED. International Journal of Infectious Diseases. 2014; 26: 44-46. https://doi.org/10.1016/j.ijid.2014.04.005
- 5. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. International Journal of Infectious Diseases. 2009; 13(3): 380-386. https://doi.org/10.1016/ j.ijid.2008.07.021
- 6. Sheikh AS, Sheikh AA, Sheikh NS, Asif M, Afridi F, Malik MT. Bi-annual surge of Crimean-Congo haemorrhagic fever (CCHF): a five-year experience. International Journal of Infectious Diseases. 2005; 9(1): 37-42. https://doi.org/ 10.1016/j.ijid.2004.02.007
- 7. Bakir, M., Ugurlu, M., Dokuzoguz, B., Bodur, H., Tasyaran, M. A., Vahaboglu, H., et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. Journal of medical microbiology. 2005; 54(4): 385-389. https://doi.org/10.1099/jmm.0.45865-0
- 8. Spengler JR, Bergeron É, Spiropoulou CF. Crimean-Congo hemorrhagic fever and expansion from endemic regions. Current opinion in virology. 2019; 34: 70-78. https://doi.org/10.1016/j.coviro.2018.12.002
Details
Primary Language
English
Subjects
Nursing
Journal Section
Review
Authors
Publication Date
January 31, 2022
Submission Date
January 18, 2022
Acceptance Date
January 28, 2022
Published in Issue
Year 2022 Volume: 17 Number: 1
